Sanofi is hoping its delayed program to switch Cialis in the US can learn lessons from the upcoming OTC launch of the erectile dysfunction treatment in the UK.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?